Dive Brief:
- Pfizer announced Tuesday that insider Cecile Guegan is its new CFO, in a unanimous board decision promoting the long-time company veteran after she took its finance reins on an interim basis in August, according to a Tuesday press release.
- The pharmaceutical company’s leadership announcement comes just months after it said it would undertake an internal and external search for a successor to Dave Denton, who left to become CFO of Nike, the Beaverton, Oregon-based sports apparel giant.
- The New York-based company’s CEO Albert Bourla expressed confidence in Guegan, describing her as an “exceptional finance leader” with deep industry knowledge and a strong track record. “Her more than 25 years of experience paired with her strategic vision will provide the financial rigor and focus this next chapter demands as we aim for meaningful growth,” he said in a statement in the release.
Dive Insight:
Guegan will be navigating a pharmaceutical industry that faces rising skepticism around vaccines and drug-makers, driven in part by the Make America Healthy Again movement.
Guegan, who joined the company as EMEA Finance director in 2005, has risen through the finance ranks to serve in various roles and business groups, including SVP Finance of the company’s biopharmaceuticals business in September 2022, according to her LinkedIn profile.
This is a developing story. Check our website for updates.
